An Overview of Target Membrane Proteins for Near-Infrared Photoimmunotherapy

Motofumi Suzuki1, Hirofumi Hanaoka1

  • 1Division of Fundamental Technology Development, Near InfraRed Photo-ImmunoTherapy Research Institute at Kansai Medical University, 2-5-1, Shin-Machi, Hirakata, Osaka 573-1010, Japan.

PubMed
Summary

Near-infrared photoimmunotherapy (NIR-PIT) uses antibody-photoabsorber conjugates and light to induce cancer cell death. Selecting optimal membrane targets and antibodies is crucial for developing future NIR-PIT drugs.